Total of 336 patients: 227 to Incruse Ellipta 125 mcg for up to 52 weeks and 109 to placebo. Adverse reactions that occurred with a frequency ≥1% in patients receiving umeclidinium 125 mcg that ...

Incruse Ellipta (umeclidinium) is a prescription drug that’s used to treat chronic obstructive pulmonary disease (COPD). The drug comes as a dry powder that you inhale. It’s typically used ...

This is typically written as 100/62.5/25 mcg. Trelegy Ellipta comes as a dry powder inhaler. You’ll inhale the powder using the Ellipta device. Your doctor or pharmacist will show you how to use ...